Back
Dorman Products Vs. Monopar Therapeutics Industry Stock Comparison
Sell
47
DORM
Dorman Products
Last Price:
$126.92
Seasonality Move:
4.21%
Sell
36
MNPR
Monopar Therapeutics
Last Price:
$31.07
Seasonality Move:
-21.29%
Sell
47
Dorman Products (DORM)
is a Sell
Is Dorman Products a Buy, Sell or Hold?
-
The current Dorman Products [DORM] share price is $126.14. The Score for DORM is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
-
DORM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
36
Monopar Therapeutics (MNPR)
is a Sell
Is Monopar Therapeutics a Buy, Sell or Hold?
-
The current Monopar Therapeutics [MNPR] share price is $30.01. The Score for MNPR is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
MNPR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DORM Stock Price Chart
What is Dorman Products's stock price today?
-
The Dorman Products share price today is $126.14The current trend is moderately bullish and DORM is experiencing selling pressure, which indicates risk of future bearish movement.
MNPR Stock Price Chart
What is Monopar Therapeutics's stock price today?
-
The Monopar Therapeutics share price today is $30.01Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MNPR is experiencing selling pressure, which indicates risk of future bearish movement.
DORM Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 4.7 | Buy |
| Relative Strength Index (14 RSI): | 52.93 | Buy |
| Chaikin Money Flow: | -140440 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (117.84 - 130.68) | Buy |
| Bollinger Bands (100): | (117.77 - 131.01) | Buy |
MNPR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.87 | Sell |
| Relative Strength Index (14 RSI): | 34.22 | Sell |
| Chaikin Money Flow: | -50258 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (33.69 - 41.55) | Sell |
| Bollinger Bands (100): | (30.59 - 43.31) | Sell |
DORM Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 127 | Sell |
| 20-day SMA: | 126.97 | Sell |
| 50-day SMA: | 120.65 | Buy |
| 200-day SMA: | 123.21 | Buy |
| 8-day EMA: | 127.48 | Sell |
| 20-day EMA: | 125 | Buy |
| 50-day EMA: | 106.9 | Buy |
| 200-day EMA: | 48.43 | Buy |
MNPR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 33.54 | Sell |
| 20-day SMA: | 36.39 | Sell |
| 50-day SMA: | 37.47 | Sell |
| 200-day SMA: | 24.75 | Buy |
| 8-day EMA: | 33.16 | Sell |
| 20-day EMA: | 35.54 | Sell |
| 50-day EMA: | 36.53 | Sell |
| 200-day EMA: | 27.37 | Buy |
Dorman Products Earnings Growth & DORM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.41 per share, an increase next quarter of $0.02 per share, an increase this year of $0.91 per share, and an increase next year of $0.67 per share.
Monopar Therapeutics Earnings Growth & MNPR Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.53 per share, an increase next quarter of $0.02 per share, a decrease this year of $0.77 per share, and an increase next year of $0.41 per share.
Dorman Products Technical Analysis
| May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Monopar Therapeutics Technical Analysis
| May 19 | May 20 | May 21 | May 22 | May 23 | May 27 | May 28 | May 29 | May 30 | Jun 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 19 | 20 | 21 | 22 | 23 | 27 | 28 | 29 | 30 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||